Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Interferon alfa-2b 25million units/2.5ml inj multidose vials
0802040J0AABEBE
|
Interferon A | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Interferon alfa-2b 30million units/1.2ml inj pf dispos dev
0802040J0AABCBC
|
Interferon A | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Interferon alfa-2b 3million unit inj vials
0802040J0AAAGAG
|
Interferon A | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Interferon alfa-2b 60million units/1.2ml inj pf dispos dev
0802040J0AABDBD
|
Interferon A | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Interferon beta-1a 12 million units/0.5ml inj 1.5ml cart
0802040M0AAAKAK
|
Interferon B | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Interferon beta-1a 12million units/0.5ml inj pf dispos dev
0802040M0AAANAN
|
Interferon B | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Interferon beta-1a 12million units/0.5ml inj pfs
0802040M0AAAGAG
|
Interferon B | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Interferon beta-1a 30microgram inj vials
0802040M0AAAEAE
|
Interferon B | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Interferon beta-1a 6million units/0.5ml inj 1.5ml cartridges
0802040M0AAAJAJ
|
Interferon B | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Interferon beta-1a 6million units/0.5ml inj pf dispos dev
0802040M0AAAMAM
|
Interferon B | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Interferon beta-1a 6million units/0.5ml inj pfs
0802040M0AAAFAF
|
Interferon B | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Interferon beta-1a 6mu/0.5ml & 2.4mu/0.2ml inj pf dev
0802040M0AAAQAQ
|
Interferon B | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Interferon beta-1a 6mu/0.5ml & 2.4mu/0.2ml inj pfs
0802040M0AAAIAI
|
Interferon B | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Interferon beta-1b 300microgram inj vials
0802040M0AAADAD
|
Interferon B | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Interferon gamma-1b (rcmb human) 100microg/0.5ml inj vials
0802040Z0AAAAAA
|
Interferon gamma-1b | Interferon gamma | Malignant Disease and Immunosuppression | No data available |
|
IntronA 10million unit inj vials
0802040J0BBACAH
|
IntronA | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
IntronA 18million units/1.2ml inj multidose pens
0802040J0BBAIBB
|
IntronA | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
IntronA 1million unit inj vials
0802040J0BBAEAK
|
IntronA | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
IntronA 25million units/2.5ml inj multidose vials
0802040J0BBALBE
|
IntronA | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
IntronA 30million units/1.2ml inj multidose pens
0802040J0BBAJBC
|
IntronA | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
IntronA 3million unit inj vials
0802040J0BBAAAG
|
IntronA | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
IntronA 60million units/1.2ml inj multidose pens
0802040J0BBAKBD
|
IntronA | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Ipilimumab 200mg/40ml solution for infusion vials
0801050BCAAABAB
|
Ipilimumab | Ipilimumab | Malignant Disease and Immunosuppression | No data available |
|
Ipilimumab 50mg/10ml solution for infusion vials
0801050BCAAAAAA
|
Ipilimumab | Ipilimumab | Malignant Disease and Immunosuppression | No data available |
|
Iressa 250mg tablets
0801050AWBBAAAA
|
Iressa | Gefitinib | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.